Expert and Patient Perspectives on Comprehensive Multiple Myeloma Treatment

Season 8 Episode 8  ·  Dec 22, 2022, 07:00 PM

Headliner
Share
Subscribe

Dr Kumar, Dr Patel, Falbo, and Ahlstrom highlight the importance of community-based discussions regarding adverse effects in multiple myeloma, the benefits of considering the whole treatment course, and subgroup analyses from the MAIA trial.

Share
Subscribe
Next
Rugo Summarizes Developments With Ribociclib and ADCs in HR-Positive Breast Cancer
Top episodes
DeNunzio Describes the Advantages of Proton Beam Therapy in Oncology
by OncLive® On Air
FDA Approval Insights: Amivantamab and Mobocertinib in EGFR Exon 20 Insertion+ NSCLC
by OncLive® On Air
Milhem Talks Mechanism of Action, Delivery Methodology, and Ongoing Trials With RP1
by OncLive® On Air